Phillips Courtney

CIK: 0001782758

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (50.0%)

Position reduction

Option Exercises (M)1 (12.5%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MAZE

Maze Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

MAZE
Maze Therapeutics, Inc.
Sep 3, 2026
Sale(S)
Direct
22 shares at avg. $25.78$567.16
MAZE
Maze Therapeutics, Inc.
Sep 3, 2026
Sale(S)
Direct
2K shares at avg. $26.01$52K
MAZE
Maze Therapeutics, Inc.
Sep 2, 2026
Sale(S)
Direct
1.7K shares at avg. $26.38$46K
MAZE
Maze Therapeutics, Inc.
Sep 2, 2026
Sale(S)
Direct
243 shares at avg. $27.12$7K
MAZE
Maze Therapeutics, Inc.
Sep 1, 2026
Exercise(M)
Direct
11K shares-
MAZE
Maze Therapeutics, Inc.
Mar 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
32K shares-
MAZE
Maze Therapeutics, Inc.
Mar 2, 2026
Award(A)
Restricted Stock Units
Direct
16K shares-
MAZE
Maze Therapeutics, Inc.
Sep 22, 2025
Award(A)
Restricted Stock Units
Direct
22K shares-

		Type	Shares	Price		Ownership
Sep 3, 2026	MAZE Maze Therapeutics, Inc.	Sale(S)	22	$25.78	$567	Direct
Sep 3, 2026	MAZE Maze Therapeutics, Inc.	Sale(S)	1,990	$26.01	$51,766	Direct
Sep 2, 2026	MAZE Maze Therapeutics, Inc.	Sale(S)	1,738	$26.38	$45,841	Direct
Sep 2, 2026	MAZE Maze Therapeutics, Inc.	Sale(S)	243	$27.12	$6,590	Direct
Sep 1, 2026	MAZE Maze Therapeutics, Inc.	Exercise(M)	11,000	-	$0	Direct
Mar 2, 2026	MAZE Maze Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	32,000	-	-	Direct
Mar 2, 2026	MAZE Maze Therapeutics, Inc.	Award(A) Restricted Stock Units	16,000	-	-	Direct
Sep 22, 2025	MAZE Maze Therapeutics, Inc.	Award(A) Restricted Stock Units	22,000	-	-	Direct

1-8 of 8 transactions

About Courtney Phillips

Courtney Phillips (SEC CIK 0001782758) files insider reports with the SEC as GC and Corp. Secretary of Maze Therapeutics, Inc. (MAZE).

Signal8 holds 5 ownership filings by Courtney Phillips (1 Form 3, 4 Form 4), filed between Jan 30, 2025 and Sep 4, 2026. Those filings report 8 transactions, from Sep 22, 2025 to Sep 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Courtney Phillips's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Courtney Phillips

Sep 3, 2026: Open-market sales of MAZE shares (2 lines, Form 4, code S).
Sep 2, 2026: Open-market sales of MAZE shares (2 lines, Form 4, code S).
Sep 1, 2026: Option exercise of MAZE shares (Form 4, code M).
Mar 2, 2026: Grants or awards of MAZE derivative securities (2 lines, Form 4, code A).
Sep 22, 2025: Grant or award of MAZE derivative securities (Form 4, code A).

Other insiders filing for Maze Therapeutics, Inc. (MAZE)

Dandekar Atul, CSBO
Coloma Jason V, Chief Executive Officer
Bernstein Harold, President, R&D & CMO
Kornowski Sophie, Director
Johnson Paula A, Director
SPIEGELMAN DANIEL K, Director

How to read Form 4 transaction codes